Nalls Sherbakoff Group’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06K Sell
130
-252
-66% -$3.91K ﹤0.01% 337
2026
Q1
$5.16K Hold
382
﹤0.01% 337
2025
Q4
$4.76K Buy
382
+252
+194% +$2.72K ﹤0.01% 371
2025
Q3
$1.29K Hold
130
﹤0.01% 397
2025
Q2
$1.16K Hold
130
﹤0.01% 400
2025
Q1
$1.13K Buy
+130
New +$1.36K ﹤0.01% 404
2023
Q4
$1.41K Hold
130
﹤0.01% 369
2023
Q3
$1.28K Hold
130
﹤0.01% 379
2023
Q2
$1.19K Hold
130
﹤0.01% 399
2023
Q1
$1.24K Buy
+130
New +$1.44K ﹤0.01% 425
2018
Q4
$12K Buy
+450
New +$14.6K 0.02% 255

Other funds holding VTRS

Nalls Sherbakoff Group's VTRS Position: Q2 2026 in Review

Nalls Sherbakoff Group reduced its Viatris (VTRS) stake by 66% in Q2 2026, selling an estimated $3.91K and leaving 130 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

Nalls Sherbakoff Group first reported a position in VTRS in Q4 2018 and has held it in 11 quarters since. The position peaked at $12K in Q4 2018. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Nalls Sherbakoff Group held 130 shares of Viatris worth $2.06K as of Q2 2026.
  • Nalls Sherbakoff Group sold 252 Viatris shares in Q2 2026, an estimated $3.91K.
  • Viatris made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #337 holding.
  • Nalls Sherbakoff Group first reported a position in Viatris in Q4 2018 and has held it in 11 quarters since.
  • Nalls Sherbakoff Group's Viatris position peaked at $12K in Q4 2018.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.